Cargando…
Corrigendum to: A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629454/ https://www.ncbi.nlm.nih.gov/pubmed/35904120 http://dx.doi.org/10.1093/neuonc/noac181 |
Ejemplares similares
-
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma
por: Law, Vincent, et al.
Publicado: (2022) -
Corrigendum to: Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson’s disease
Publicado: (2021) -
Corrigendum: Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids
por: Wang, Qilong, et al.
Publicado: (2016) -
Corrigendum: Experimental Models in Syrian Golden Hamster Replicate Human Acute Pancreatitis
por: Wang, Yunan, et al.
Publicado: (2016) -
Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma
por: Coni, Sonia, et al.
Publicado: (2017)